Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

41.50
-0.9400-2.21%
Post-market: 41.500.00000.00%16:11 EDT
Volume:442.11K
Turnover:18.29M
Market Cap:1.74B
PE:-15.27
High:42.54
Open:42.54
Low:40.75
Close:42.44
Loading ...
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 25, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 17, 2020

Major Issues Report

8-K - Current report
Oct 30, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 30, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 28, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 23, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 20, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 20, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 09, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 09, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 25, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933